default author photo

Peter D. Kwong

National Institutes of Health - Vaccine Research Center

Bethesda, MD 20892-9806

United States

SCHOLARLY PAPERS

9

DOWNLOADS

324

TOTAL CITATIONS

4

Scholarly Papers (9)

1.

Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains

Number of pages: 65 Posted: 26 Oct 2020
National Institutes of Health - Vaccine Research Center, Frederick National Laboratory for Cancer Research - Electron Microscopy Laboratory, National Institutes of Health - Vaccine Research Center, Columbia University - Department of Biochemistry and Molecular Biophysics, Columbia University - Department of Biochemistry and Molecular Biophysics, National Institutes of Health - Vaccine Research Center, Columbia University - Department of Biochemistry and Molecular Biophysics, Columbia University - Department of Biochemistry and Molecular Biophysics, Johns Hopkins University - Department of Biology, Columbia University - Department of Biochemistry and Molecular Biophysics, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Frederick National Laboratory for Cancer Research - Electron Microscopy Laboratory, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Columbia University - Department of Chemistry, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 47 (1,097,529)
Citation 2

Abstract:

Loading...

ACE2 receptor, endosomal entry, pH-dependent switch, receptor-binding domain (RBD), structural rearrangement, type 1 fusion machine

2.

Molecular Dissection Of Human Antibody Responses Following Prefusion-Stabilized RSV F Vaccination

Number of pages: 58 Posted: 28 Oct 2020
National Institutes of Health - Vaccine Research Center, University of Texas at Austin - Department of Molecular Biosciences, National Institutes of Health - Vaccine Research Center, University of Texas at Austin - Department of Molecular Biosciences, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Texas at Austin - Department of Molecular Biosciences, University of Kansas - Department of Pharmaceutical Chemistry, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Kansas - Bioengineering Graduate Program, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Texas at Austin - Department of Molecular Biosciences and National Institutes of Health - Vaccine Research Center
Downloads 44 (1,133,231)

Abstract:

Loading...

Respiratory syncytial virus (RSV), Fusion glycoprotein (F), memory B cells, neutralizing antibodies, antibody repertoire, public clonotypes, cryo-EM structure

3.

Impact of Glycan Positioning on HIV-1 Env Glycan Shield Density, Function, and Antibody Recognition

Number of pages: 70 Posted: 10 Jun 2020
University of Alabama at Birmingham - Department of Microbiology, University of Alabama at Birmingham - Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham - Department of Microbiology, University of Alabama at Birmingham - Department of Medicine, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, University of Alabama at Birmingham - Department of Microbiology, University of Alabama at Birmingham - Department of Microbiology, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, University of Alabama at Birmingham - Department of Medicine, University of Alabama at Birmingham - Department of Medicine, University of Alabama at Birmingham - Department of Medicine, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Alabama at Birmingham - Department of Microbiology, Palacký University Olomouc - Department of Immunology, University of Alabama at Birmingham - Department of Biochemistry and Molecular Genetics and University of Alabama at Birmingham - Department of Microbiology
Downloads 40 (1,183,237)

Abstract:

Loading...

envelope, glycomics, glycoprotein, gp120, HIV-1

4.

Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Number of pages: 43 Posted: 05 Aug 2019
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Health Laboratory Services (NHLS) - Centre for HIV and STIs, University of the Witwatersrand, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 40 (1,183,237)
Citation 1

Abstract:

Loading...

broadly neutralizing antibody, HIV-1 envelope trimer, multidonor antibody class, PCT64, PG9, PGDM1400, PGT145, tyrosine sulfation, V1V2-apex recognition

5.

Paired Heavy and Light Chain Signatures Contribute to Potent SARS-CoV-2 Neutralization in Public Antibody Responses

Number of pages: 58 Posted: 23 Dec 2020
University of Kansas - Bioengineering Graduate Program, Columbia University - Department of Biochemistry and Molecular Biophysics, University of Kansas - Department of Pharmaceutical Chemistry, National Institutes of Health - Vaccine Research Center, University of Kansas - Department of Pharmaceutical Chemistry, Columbia University - Department of Biochemistry and Molecular Biophysics, Frederick National Laboratory for Cancer Research - Electron Microscopy Laboratory, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, University of Colorado at Boulder - Department of Chemical and Biological Engineering, University of Colorado at Boulder - Department of Chemical and Biological Engineering, University of Kansas - Department of Pharmaceutical Chemistry, Columbia University - Aaron Diamond AIDS Research Center, University of Kansas - Department of Pharmaceutical Chemistry, National Institutes of Health - Vaccine Research Center, University of Kansas - Department of Pharmaceutical Chemistry, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Columbia University - Department of Biochemistry and Molecular Biophysics, National Institutes of Health - Vaccine Research Center, Columbia University - Department of Biochemistry and Molecular Biophysics, Columbia University - Department of Biochemistry and Molecular Biophysics, University of Kansas - Department of Pharmaceutical Chemistry, University of Kansas - Department of Pharmaceutical Chemistry, University of Kansas - Department of Pharmaceutical Chemistry, University of Kansas - Department of Pharmaceutical Chemistry, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, University of Colorado at Boulder - Department of Chemical and Biological Engineering, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center and University of Kansas - Bioengineering Graduate Program
Downloads 37 (1,222,651)

Abstract:

Loading...

SARS-CoV-2, public antibody, neutralization, yeast display

6.

Anti-V2 Antibodies Virus Vulnerability Revealed by Envelope V1 Deletion in HIV Vaccine Candidates

Number of pages: 87 Posted: 21 Oct 2020
National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health (NIH) - Section on Intercellular Interactions, Advanced Bioscience Laboratories, Advanced Bioscience Laboratories, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Structural Biology Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Medical Center, Duke University - Duke Human Vaccine Institute, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute - Biostatistics and Data Management Section, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Section on Intercellular Interactions, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, New York University (NYU) - NYU Langone Health and Medical University of Bialystok - Centre for Bioinformatics and Data Analysis
Downloads 33 (1,277,121)

Abstract:

Loading...

HIV, SIV, V1/V2, V1, ALVAC

7.

Vaccination Induces Maturation of Diverse Unmutated VRC01-Class Precursors to HIV-1 Broadly Neutralizing Antibodies in an Ig-Humanized Mouse Model

Number of pages: 156 Posted: 15 Sep 2020
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Boston Children’s Hospital - Program in Cellular and Molecular Medicine, Boston Children’s Hospital - Program in Cellular and Molecular Medicine, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 33 (1,277,121)

Abstract:

Loading...

antibody VRC01, broadly neutralizing antibody, HIV-1 vaccine, somatic hypermutations

8.

A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention

Number of pages: 41 Posted: 05 Oct 2020
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Independent, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Viral Pathogenesis Section, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 27 (1,359,097)
Citation 1

Abstract:

Loading...

antibody VRC01, broadly neutralizing antibody, HIV-1 envelope trimer, polyreactivity, prophylaxis, treatment

9.

The N Terminus of H3-Influenza Hemagglutinin as a Site-of-Vulnerability to Neutralizing Antibody

Number of pages: 50 Posted: 05 Mar 2025
National Institutes of Health - Vaccine Research Center, Columbia University, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Columbia University, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Columbia University, National Institutes of Health - Vaccine Research Center and Independent
Downloads 23 (1,411,822)

Abstract:

Loading...

Cryo-EM, immune focusing, influenza H3 N terminus, peptide immunization, prime-boost, structure-based vaccine design